Theravance Biopharma, Inc. (TBPH)
16.79
+0.05
(+0.30%)
USD |
NASDAQ |
May 01, 16:00
16.78
-0.01
(-0.06%)
After-Hours: 20:00
Theravance Biopharma Market Cap : 864.57M for May 1, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Integer Holdings Corp. | 2.863B |
| Catalyst Pharmaceuticals, Inc. | 3.510B |
| QuidelOrtho Corp. | 860.55M |
| Viatris, Inc. | 17.32B |
| Relmada Therapeutics, Inc. | 801.36M |
Market Cap Related Metrics
| PE Ratio | 8.281 |
| PS Ratio | 8.023 |
| Price to Book Value | 2.914 |
| Price to Free Cash Flow | 3.615 |
| Price | 16.79 |
| Earnings Yield | 12.08% |
| Normalized PE Ratio | 8.280 |